Market Cap 46.31M
Revenue (ttm) 31.99M
Net Income (ttm) 400,000.00
EPS (ttm) N/A
PE Ratio 556.00
Forward PE N/A
Profit Margin 1.25%
Debt to Equity Ratio -0.88
Volume 7,138
Avg Vol 14,680
Day's Range N/A - N/A
Shares Out 8.08M
Stochastic %K 38%
Beta 0.59
Analysts Strong Sell
Price Target $8.50

Latest News on CCEL

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

Mar 9, 2022, 4:15 PM EST - 3 years ago

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders